NGeneBio (엔젠바이오)

Seoul, South Korea

Cancer Diagnostics & Monitoring Precision Medicine/Diagnostics Biotech

NGeneBio (엔젠바이오) is a leading company in molecular diagnostics (MDx) and companion diagnostics (CDx), which develops and provides next generation sequencing (NGS)-based in vitro diagnostics (IVD) panel and clinical analysis software (SW). NGeneBio was as a joint venture between Genecurix and Korea Telecom. The company launched NGS-based hereditary breast/ovarian cancer panel (BRCAaccuTestTM) with clinical analysis SW (NGeneAnalysisTM) in 2016. BRCA NGS panel for PARP inhibitor CDx test and solid tumor/hematologic cancer NGS panels will be launched, inclusive of clinical data analysis SW platform. The mission of the company is to provide clinically validated NGS based IVD/CDx products/services with convergence of innovative bioinformatics and SW development capacity for global market.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out NGeneBio (엔젠바이오) on @MedStartr Today #BreastCancer #OvarianCancer #HematologicMalignancies #Cancer #DiagnosticsScreeningMonitoring #PrecisionMedicineDiagnostics #Biotech #MedMo #MedStartrVentures

https://www.medstartr.ai/s/Fklh4motfps

Get Involved in NGeneBio (엔젠바이오)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2015
Website: www.ngenebio.com/

Disease Areas

Breast Cancer Ovarian Cancer Hematologic Malignancies

Technologies

Next-Generation SequencingMolecular DiagnosticsGenetic TestingCompanion Diagnostics

🌐Website

What do you think of NGeneBio (엔젠바이오)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.